|
Volumn 9, Issue 2, 2000, Pages 269-274
|
A randomized trial of leukapheresis volumes, 7 L versus 10 L: An assessment of efficacy and patient tolerance
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CD34 ANTIGEN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
PREDNISOLONE;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
VINCRISTINE;
ADULT;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
FEMALE;
HUMAN;
LEUKAPHERESIS;
LEUKEMIA;
LEUKOCYTE COUNT;
LYMPHOMA;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
ANTIGENS, CD34;
BLOOD CELL COUNT;
BLOOD VOLUME;
DRUG TOLERANCE;
EVALUATION STUDIES;
FEMALE;
HEMOGLOBINS;
HUMANS;
LEUKAPHERESIS;
MALE;
MIDDLE AGED;
PATIENT ACCEPTANCE OF HEALTH CARE;
QUALITY CONTROL;
QUESTIONNAIRES;
TIME FACTORS;
|
EID: 0034103811
PISSN: 15258165
EISSN: None
Source Type: Journal
DOI: 10.1089/152581600319496 Document Type: Article |
Times cited : (7)
|
References (8)
|